Tao, Jingjing https://orcid.org/0000-0001-6473-3797
Wang, Zheng https://orcid.org/0000-0001-6277-3269
Shi, Rongkai
Lin, Liming
Li, Min
Meng, Ying https://orcid.org/0000-0002-1165-9009
Luo, Shudi
Jiang, Xiaoming
Guo, Zhanpeng
Shang, Yongfeng https://orcid.org/0000-0001-5050-7625
Lu, Zhimin https://orcid.org/0000-0002-2859-2736
Article History
Received: 31 January 2024
Accepted: 10 December 2024
First Online: 17 January 2025
Competing interests
: Z.L. holds shares in Signalway Biotechnology, the supplier of rabbit antibodies targeting TK1 pS231. However, this affiliation did not influence the choice of reagents used in the study. The other authors declare no competing interests.